头孢哌酮／舒巴坦用于胸外科感染的疗效分析  

Analysis of efficacy of cefoperazone/sulbactam in treatment of infection of thoracic surgery

作　　者：梁永福[1] 胡荣波[1] 司华[1] 

机构地区：[1]河南省南阳市第二人民医院心胸外科,473012

出　　处：《医学信息（下旬刊）》2010年第8期120-120,共1页Medical information

摘　　要：目的：观察和评价头孢哌酮／舒巴坦应用于普胸外科手术的，临床疗效和安全性。方法：采用对比试验，观察2009年5月~2010年5月96例普胸手术预防和治疗的疗效和不良反应。结果：头孢哌酮／舒巴坦在预防和治疗术后感染中总有效率95．9％，不良反应发生率5．2％。结论：头孢哌酮／舒巴坦临床疗效满意，使用安全，值得在普胸手术中选用。Objective To observe and evaluate the clinical effect and safety of cefoperazone/sulbactam for injection used in general thoracic surgery. Methods The clinical effect and side effect after application of cefoperazone/sulbactam on 96 operative cases from May in 2009 to May in 2010 were observed and evaluated. Results The total effective rate of cefoperazone/sulbactam was 95.9%, the rate of adverse reaction of cefoperazone/sulbactam was 5.2%. Conclution Cefoperazone/sulbactam is an effective and safe antibiotic. It might be one of the drug of choice for general thoracic surgery.

关 键 词：头孢哌酮/舒巴坦 感染 疗效 

分 类 号：R978.1[医药卫生—药品]